top of page
Search


Memorify Secures £45,000 from ACG Angels at November Pitching Event
We at ACG are proud to shine the spotlight on Memorify , which secured £45,000 from four of our angel investors at our last pitching round on 25th November 2025 in Norwich. Memorify delivered a compelling pitch to ACG members, clearly articulating the emotional drive behind the business and its commercial potential. The company’s mission is rooted in a deeply personal story as founder Charlotte Ridley shares: “The loss of my father whilst pregnant with my daughter sparke
Libby
Feb 171 min read


FRP Joins Anglia Capital Group as New Corporate Sponsor
pleased to announce that FRP, the national specialist business advisory firm, has joined ACG as our newest corporate sponsor. FRP provides expert advisory services across corporate finance, restructuring, debt advisory, financial advisory and forensic services, supporting businesses at every stage of their lifecycle. Their partnership with ACG reflects a shared commitment to strengthening the regional investment ecosystem and supporting ambitious, high-growth companies acro
Libby
Feb 171 min read


New Angel Investor Training Programme Launched
At ACG we want to support more individuals on their journey into investing, we re delighted to bring a new-style angel investor training programme to our region.
laura062379
Jan 71 min read


Driving Men’s Fertility Innovation: ACG Angels Invest £100k in Virilitas Labs
Professor Simone Immler and Dr Daniel Marcu; masterminds behind Virilitas Labs Anglia Capital Group (ACG) is delighted to welcome Virilitas Labs into its investment portfolio following a £100,000 investment secured through ACG’s funding round in February. Based at Norwich Research Park , Virilitas Labs is developing rapid, at-home male fertility tests supported by AI-driven analysis — addressing a major gap in reproductive health diagnostics for men. Co-founded by Dr Daniel
Libby
Nov 27, 20252 min read
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
bottom of page
